The Federal Circuit (CAFC) affirmed a Patent Trial and Appeal Board (PTAB or Board) ruling that claims of DexCom, Inc.’s patent for implantable glucose sensors were unpatentable as obvious. As the court explained, This appeal involves implantable g… Read More